4Mariino R, SubiraM, Rovira M, et al. Inwasive fungal infections af- ter allogenic peripheral blood stem cell transplantation: incidence and risk factorsin 395 patients. Br .I tlaemalo1,2002,116:475-482. 被引量：1
5Denning DW, Marinus A, Cohen J, el al. At, EORTC muhicentre prospective survey of invasive aspergillosis in haenmtological paients : diagnosis and the,'apeuti lnfeclions Cooperative Group. J Infeet1998,37:137-180. 被引量：1
6Wingard JR. New approaches to invasive fungal infections in acufc leukemia and heruatopoielic slem cell trarlsplanl palients. Besl Pracl Res Clin Haemalo1,2007,20 : 99-107. 被引量：1
8Sehuler U, Bammer S Aulitzkv WE, et al. Safely and efficaey of itraconazole compared to amphotericin B as empirical antiiungaltherapy for neutropenic fever in patients with haematological ma- lignancy. Onkologie, 2007,30 : 185-191. 被引量：1
9Jantunen E,Anttila VJ, Ruutu T. Aspergiltus infections in alloge- neic stem cell transplant recipients:have we made any progress? Bone Marrow Transplant ,2002,30:925-929. 被引量：1
10Eltern T, Sieniawski M, Gossmann A, et al. Voriconazole brain tis- sue levels in rhinocerebral aspergillosis in a successfully treated young woman. Int J Antimicrob Agents,2006,28:262-265. 被引量：1
